Stereotaxis (STXS) EPS (Weighted Average and Diluted) Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn |
| 10 | Stereotaxis | 187.40 Mn | 172.78 Mn | 3.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -24.57% |
| Dec 31, 2025 | -24.57% |
| Sep 30, 2025 | -18.47% |
| Jun 30, 2025 | -10.76% |
| Mar 31, 2025 | -18.47% |
| Dec 31, 2024 | -24.57% |
| Sep 30, 2024 | -73.01% |
| Jun 30, 2024 | -18.47% |
| Mar 31, 2024 | -8.45% |
| Dec 31, 2023 | -24.57% |
| Sep 30, 2023 | -47.58% |
| Jun 30, 2023 | -28.47% |
| Mar 31, 2023 | -55.18% |
| Dec 31, 2022 | 12.94% |
| Sep 30, 2022 | 19.73% |
| Jun 30, 2022 | -28.47% |
| Mar 31, 2022 | -51.57% |
| Dec 31, 2021 | -17.17% |
| Sep 30, 2021 | 34.02% |
| Jun 30, 2021 | 28.89% |
| Mar 31, 2021 | 28.89% |
| Dec 31, 2020 | 24.21% |
| Sep 30, 2020 | 9.71% |
| Jun 30, 2020 | 15.59% |
| Mar 31, 2020 | 27.52% |
| Dec 31, 2019 | -22.42% |
| Jun 30, 2019 | 21.40% |
| Mar 31, 2019 | 28.23% |
| Dec 31, 2018 | 38.64% |
| Sep 30, 2018 | 70.52% |
| Jun 30, 2018 | 44.21% |
| Mar 31, 2018 | 15.06% |
| Dec 31, 2017 | 26.25% |
| Sep 30, 2017 | 3.43% |
| Jun 30, 2017 | -15.58% |
| Mar 31, 2017 | 14.98% |
| Dec 31, 2016 | 17.50% |
| Sep 30, 2016 | 15.89% |
| Jun 30, 2016 | 42.63% |
| Mar 31, 2016 | 42.50% |